We are live on ! Find out more
Comerica Bank

Comerica Bank Portfolio holdings

AUM $25.1B
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+24.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$24B
AUM Growth
+$822M
Cap. Flow
+$431M
Cap. Flow %
1.79%
Top 10 Hldgs %
23.54%
Holding
3,858
New
118
Increased
1,045
Reduced
1,974
Closed
158

Sector Composition

Rank Sector Weight
1 Technology 19.7%
2 Healthcare 14.1%
3 Financials 8.87%
4 Industrials 7.86%
5 Consumer Discretionary 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGXU icon
2026
Capital Group International Focus Equity ETF
CGXU
$6.25B
$332K ﹤0.01%
12,917
+4,802
+59% +$124K
DBAW icon
2027
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$287M
$331K ﹤0.01%
9,914
-76
-0.8% -$2.52K
RBLX icon
2028
Roblox
RBLX
$26.3B
$331K ﹤0.01%
8,882
+2,525
+40% +$89.9K
BNL icon
2029
Broadstone Net Lease
BNL
$4.09B
$330K ﹤0.01%
20,821
+3,945
+23% +$59.7K
PDX
2030
PIMCO Dynamic Income Strategy Fund
PDX
$955M
$329K ﹤0.01%
14,781
+546
+4% +$11.6K
LYTS icon
2031
LSI Industries
LYTS
$884M
$328K ﹤0.01%
22,680
-34
-0.1% -$513
JBSS icon
2032
John B. Sanfilippo & Son
JBSS
$992M
$327K ﹤0.01%
3,370
-447
-12% -$44.7K
PSK icon
2033
State Street SPDR ICE Preferred Securities ETF
PSK
$689M
$326K ﹤0.01%
9,604
+663
+7% +$22.4K
RWX icon
2034
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
$326K ﹤0.01%
13,564
+293
+2% +$7.35K
CPNG icon
2035
Coupang
CPNG
$29.9B
$325K ﹤0.01%
15,526
+15,005
+2,880% +$325K
BBIO icon
2036
BridgeBio Pharma
BBIO
$15.7B
$324K ﹤0.01%
12,795
-25,719
-67% -$703K
TPYP icon
2037
Tortoise North American Pipeline ETF
TPYP
$870M
$323K ﹤0.01%
11,193
+10,907
+3,814% +$306K
VCTR icon
2038
Victory Capital Holdings
VCTR
$6.37B
$322K ﹤0.01%
6,754
-92
-1% -$4.5K
QQQX icon
2039
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.46B
$321K ﹤0.01%
12,792
-5
-0% -$119
APLS
2040
DELISTED
Apellis Pharmaceuticals
APLS
$321K ﹤0.01%
8,355
+192
+2% +$8.7K
GOF icon
2041
Guggenheim Strategic Opportunities Fund
GOF
$2.23B
$319K ﹤0.01%
21,402
+93
+0.4% +$1.35K
RBCAA icon
2042
Republic Bancorp
RBCAA
$1.96B
$319K ﹤0.01%
5,950
QNST icon
2043
QuinStreet
QNST
$908M
$317K ﹤0.01%
19,123
-2,434
-11% -$42.2K
CSM icon
2044
ProShares Large Cap Core Plus
CSM
$522M
$317K ﹤0.01%
5,106
-1,023
-17% -$61.2K
ICSH icon
2045
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.12B
$315K ﹤0.01%
6,225
-38
-0.6% -$1.92K
TILE icon
2046
Interface
TILE
$2.03B
$314K ﹤0.01%
21,406
-2,642
-11% -$41.1K
DNP icon
2047
DNP Select Income Fund
DNP
$4.06B
$314K ﹤0.01%
38,210
+1,429
+4% +$12.4K
ONT
2048
Onterris Inc
ONT
$784M
$314K ﹤0.01%
7,046
-375
-5% -$16.9K
HFWA icon
2049
Heritage Financial
HFWA
$1.23B
$314K ﹤0.01%
17,412
-1,840
-10% -$33K
LOOP icon
2050
Loop Industries
LOOP
$35.3M
$314K ﹤0.01%
150,118

Similar funds

Comerica Bank's Q2 2024 Portfolio in Review

As of Q2 2024, Comerica Bank held 3,858 positions worth $24B, up 3.5% from $23.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Comerica Bank's Q2 2024 filing shows 118 new, 1,045 increased, 1,974 reduced and 158 closed positions. Its largest new stake was Solventum: 36,995 shares worth $1.96M. The largest sale was Invesco QQQ Trust, an estimated $107M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Comerica Bank's largest Q2 2024 buy was Solventum: 36,995 shares worth $1.96M.
  • Comerica Bank added most to Eli Lilly in Q2 2024, an estimated $505M increase.
  • Comerica Bank's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $107M.
  • Comerica Bank fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $10.7M.
  • Comerica Bank's ten largest holdings make up 24% of its $24B portfolio in Q2 2024.
  • Comerica Bank opened 118 new positions and closed 158 in Q2 2024.
  • Comerica Bank's portfolio value rose 3.5% quarter-over-quarter to $24B.

Based on Comerica Bank's 13F filing for Q2 2024, filed 15 Aug 2024.